These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14718333)

  • 21. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypertension on anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M;
    Eur Heart J; 2007 Mar; 28(6):752-9. PubMed ID: 17289744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 25. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
    Watson T; Kakar P; Lip GY
    Int J Clin Pract; 2007 Jan; 61(1):6-9. PubMed ID: 17229172
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
    Jolobe OM
    J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207
    [No Abstract]   [Full Text] [Related]  

  • 29. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 30. [Between Scylla and Charybdis].
    Brean A
    Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1322. PubMed ID: 19561655
    [No Abstract]   [Full Text] [Related]  

  • 31. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?].
    MMW Fortschr Med; 2006 Sep; 148(38):14. PubMed ID: 17036954
    [No Abstract]   [Full Text] [Related]  

  • 32. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial.
    Pérez-Gómez F; Iriarte JA; Zumalde J; Berjón J; Salvador A; Alegría E; Maluenda MP; Asenjo S; Perez-Saldaña R; de la Torre RG; Bover R; Fernández C
    Eur Heart J; 2007 Apr; 28(8):996-1003. PubMed ID: 17158523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral anticoagulation in elderly people].
    Rochat S; Büla C
    Rev Med Suisse; 2005 Nov; 1(39):2505-6, 2509-11. PubMed ID: 16323730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.
    Ono A; Fujita T
    J Clin Neurosci; 2005 Nov; 12(8):891-4. PubMed ID: 16271478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 38. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.
    Odén A; Fahlén M; Hart RG
    Thromb Res; 2006; 117(5):493-9. PubMed ID: 16517250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.